In addition, IBD medications and granulocyte colony-stimulating factor (G-CSF) can be administered.3 Recently, sodium-glucose cotransporter 2 inhibitors have shown great efficacy and altered the progression of GSDIb.4 The gene discussed is CSF3; the disease is glycogen storage disease Ib.